Literature DB >> 9449654

A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1.

M L Lamm1, S M Sintich, C Lee.   

Abstract

Transforming growth factor -beta (TGF-beta) is growth inhibitory to many malignant cells, including prostate cancer cells. The present study reports an unusual observation in that TGF-beta is growth stimulatory to a human prostate cancer cell line, TSU-Pr1. The TSU-Pr1 line is highly aggressive and exhibits a rapid rate of proliferation in culture. These cells underwent further proliferation in response to TGF-beta1. Both type I and II receptors to TGF-beta (TPR-I, TPR-II) are expressed in TSU-Pr1 cells. Activation of a luciferase reporter gene, which contains a TGF-beta response element, confirmed that the TGF-beta receptors in TSU-Pr1 cells were functional. RT-PCR analysis and an ELISA assay determined that TSU-Pr1 cells secreted TGF-beta. In conclusion, TSU-Pr1 cells contain functional TGF-beta receptors but instead of the usual growth inhibition by TGF-beta1, these cells undergo proliferation. The present observation provides a proliferative role of TGF-beta in TSU-Pr1 cells, which may play a part in the aggressive phenotype of these cells and, perhaps other prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449654     DOI: 10.1210/endo.139.2.5907

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.

Authors:  J Lawler; W M Miao; M Duquette; N Bouck; R T Bronson; R O Hynes
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system.

Authors:  Philip A Klenotic; Richard C Page; Saurav Misra; Roy L Silverstein
Journal:  Protein Expr Purif       Date:  2011-07-29       Impact factor: 1.650

3.  Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.

Authors:  Xin Li; Baotong Zhang; Qiao Wu; Xinpei Ci; Ranran Zhao; Zhiqian Zhang; Siyuan Xia; Dan Su; Jie Chen; Gui Ma; Liya Fu; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2014-06-28       Impact factor: 7.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.